Figure 3

CD73 expression and 89Zr-CD73 IgG binding in 4T1.2 breast cancer cells. (A) Immunoblotting and quantified band intensities of CD73 protein in 4T1.2 cells compared to overexpressing CT26/CD73 cells. (B) 89Zr-CD73 IgG binding in 4T1.2 cells compared to equal number of CT26/CD73 cells, and effect of blocking with excess unlabeled anti-CD73 antibody. All data are the mean ± standard deviation values obtained from a single experiment (n = 3 per group).